Published in Cardiovascular Business Week, March 14th, 2006
Sequentially, revenue increased $171,900 or 18.7% from the $917,300 reported for the quarter ended September 30, 2005. The operating loss for the fourth quarter was $615,600, a decrease of $98,900 or 13.8% compared to $714,500 in 2004. The net loss for the quarter was $562,500 or $0.01 per share compared to a loss of $3,291,700 or $0.10 per share, for the same quarter last year.
Last year's net loss included a non-cash charge of $2,603,900, or $0.08 per...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.